No ownership or control links for ZENG XUEBO are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is ZENG XUEBO's risk level?

WhiteIntel flags ZENG XUEBO as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does ZENG XUEBO appear across sources?

ZENG XUEBO is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

ZENG XUEBO

Name: ZENG XUEBO — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, ZENG XUEBO, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 1

/02

Key facts

Risk signal

Low

Risk

ZENG XUEBO is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

ZENG XUEBO
- CASI PHARMACEUTICALS HOLDINGS, INC.· director· via SEC EDGAR

/04

Directorship network

11 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

CASI PHARMACEUTICALS HOLDINGS, INC.

FOLINSBEE THOMASdirector
WANG CHUNHUAofficer
HUANG HAIofficer
GAO WEI Rofficer
QIAN KUNofficer
ZUKIWSKI ALEXANDER Aofficer
HUANG JAMESdirector
WU ALEXdirector
HE WEI-WUdirector
HE WEI-WUtenpercentowner
KREBS-POHL BARBARA HELENE HANNELOREdirector

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on ZENG XUEBO. Notes are community-contributed leads, not verified facts.

Loading notes…